Veradermics' CEO is Reid Waldman, appointed in Dec 2022, has a tenure of 3.67 years. total yearly compensation is $8.46M, comprised of 5.3% salary and 94.7% bonuses, including company stock and options. directly owns 0.56% of the company’s shares, worth $26.13M. The average tenure of the management team and the board of directors is 1.1 years and 4.9 years respectively.
How has Reid Waldman's remuneration changed compared to Veradermics's earnings?
Date
Total Compensation
Salary
Company Earnings
Jun 30 2026
n/a
n/a
-US$104m
Mar 31 2026
n/a
n/a
-US$99m
Dec 31 2025
US$8m
US$450k
-US$83m
Sep 30 2025
n/a
n/a
-US$62m
Dec 31 2024
US$812k
US$371k
-US$27m
Compensation vs Market: Reid's total compensation ($USD8.46M) is about average for companies of similar size in the US market ($USD6.93M).
Compensation vs Earnings: Reid's compensation has increased whilst the company is unprofitable.
CEO
Reid Waldman (31 yo)
3.7yrs
Tenure
US$8,455,507
Compensation
Dr. Reid Waldman, M.D., serves as Director at Achieve Life Sciences, Inc. since May 29, 2026. He is co-founder and Director of VeraDermics, Inc. since October 2019 and has been its Chief Executive Officer...
Leadership Team
Name
Position
Tenure
Compensation
Ownership
Reid Waldman
CEO & Director
3.7yrs
US$8.46m
0.56% $ 26.1m
Dominic Carrano
CFO & Treasurer
1.5yrs
US$2.21m
0% $ 0
Timothy Durso
Chief Technical Officer
less than a year
US$3.31m
0.56% $ 26.1m
Michael Greco
General Counsel & Secretary
1.1yrs
no data
no data
Karl Pruss
Senior Director of Manufacturing Sciences & Technology
no data
no data
no data
Mark Neumann
Chief Commercial & Strategy Officer
less than a year
no data
no data
Erika Sipperly
Controller
no data
no data
no data
Michael Smolinski
Vice President of Development & Scientific Operations
no data
no data
no data
Aron Shapiro
Vice President of Clinical Development & Regulatory Affairs
no data
no data
no data
Brian Trautman
Director of CMC Project Management
no data
no data
no data
Barbara Szymaszek
Director of Clinical Operations
no data
no data
no data
Elizabeth Lindemann
Associate Director of Medical Affairs
no data
no data
no data
1.1yrs
Average Tenure
48yo
Average Age
Experienced Management: MANE's management team is not considered experienced ( 1.1 years average tenure), which suggests a new team.
Board Members
Name
Position
Tenure
Compensation
Ownership
Reid Waldman
CEO & Director
6.8yrs
US$8.46m
0.56% $ 26.1m
John Childs
Independent Non-Employee Director
4.9yrs
no data
5.27% $ 244.9m
Patrick Gerald Enright
Independent Non-Employee Director
1.7yrs
no data
no data
David Friedman
Independent Non-Employee Director
less than a year
no data
no data
Vladimir Coric
Independent Non-Employee Director
4.9yrs
US$7.89k
1.56% $ 72.4m
Katarina Pance
Independent Non-Employee Director
less than a year
no data
no data
Jane Grant-Kels
Independent Non-Employee Director
4.9yrs
no data
0.054% $ 2.5m
4.9yrs
Average Tenure
55yo
Average Age
Experienced Board: MANE's board of directors are considered experienced (4.9 years average tenure).
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/08/20 05:46
End of Day Share Price
2026/08/20 00:00
Earnings
2026/06/30
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Veradermics, Incorporated is covered by 6 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.